Radiologists may have to make only minor changes to their practices to adjust to the new international standards for lung cancer staging, but a lecture covering their implications was still controversial enough to send sparks flying Aug. 4 at the World Conference on Lung Cancer in San Francisco. The point of contention during a question and answer session arose after plenary lecturer Dr. Ned Patz, a thoracic radiologist from Duke University, recommended noncontrast thoracic CT for staging. He had advised some 2000 physicians in the audience that contrast enhancement is a hotly debated question. That point proved true when Dr. John C. Ruckdeschel, CEO of the Nevada Cancer Institute, took to the microphone to challenge the recommendation.
![](https://storage.ning.com/topology/rest/1.0/file/get/396595535?profile=original)
See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC
You need to be a member of radRounds Radiology Network to add comments!
Join radRounds Radiology Network